Oxaprozin
- Level
- Commodity
- Parent
- 51384500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384515This classification denotes a cyclooxygenase inhibitor with the molecular formula C18H15NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MHJ80W9LRB, chemically known as 4,5-diphenyl-2-oxazolepropionic acid but generally known as oxaprozin, which bears US NIH Compound Identifier 4614. European Medicines Agency schedules Oxaprozin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09502MIG. The term OXAPROZIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules oxaprozin in its Anatomical Therapeutic Chemical (ATC) Classification. OXAPROZIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxaprozin under HS 29349990 and SITC 51579. As of Q4 2014, OXAPROZIN remains the US FDA Preferred Term for this commodity. Oxaprozin bears US NLM identifiers UMLS ID C0603695 and NCI Concept Code C29307. SMILES: O1C(C(NC1CCC(=O)O)C1CCCCC1)C1CCCCC1.
Same parent
Under 51384500 · 34Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.